
Lupin Limited has informed the Exchange regarding a press release dated July 15, 2024, titled "Lupin Divests U.S. Commercial Women s Health Specialty Business to Evofem,including SOLOSEC".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated July 15, 2024, titled "Lupin Divests U.S. Commercial Women s Health Specialty Business to Evofem,including SOLOSEC".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin